The Latest Cardiac and Vascular News
SANTA MONICA, Calif. & EMERYVILLE, Calif.–(BUSINESS WIRE)–FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, and Eko Health, Inc. (“Eko”), a leading innovator in digital health technology for heart and lung disease detection, today announced the launch of the FIGS | Eko CORE 500™ Digital Stethoscope. “FIGS has built an innovative […]
TOKYO, EMERYVILLE, Calif. and COLUMBIA, Md., July 18, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Eko Health Inc. (Co-Founder and CEO: Connor Landgraf, “Eko”) announced today that they have entered into a License & Supply Agreement for the global supply and license of Eko’s latest digital stethoscope, the CORE 500™, and […]
Next-generation FDA-cleared medical device brings non-invasive heart and lung disease detection to healthcare professionals at the point of care EMERYVILLE, Calif., June 27, 2023 /PRNewswire/ — Eko Health, a leading innovator in digital health technology for heart and lung disease detection, today announced the launch of its next-generation digital stethoscope, CORE 500™. The CORE […]
For the second consecutive year, Eko Health honored with Fast Company’s World Changing Ideas Awards and Inc. Magazine’s Best Workplaces OAKLAND, Calif., May 23, 2023 /PRNewswire/ — Eko Health, a leading innovator in digital health technology for heart and lung disease detection, today announced that it has been honored in Fast Company’s World Changing […]
Enterprise-grade digital stethoscope platform brings non-invasive heart disease detection to primary care OAKLAND, Calif., Feb. 23, 2023 /PRNewswire/ — Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease, today announced the launch of the SENSORA™ Cardiac Disease Detection Platform. SENSORA™ currently features AI that objectively identifies structural […]
Eko’s AI-powered smart stethoscopes recognized for innovation in heart disease detection three years in-a-row OAKLAND, Calif., Dec. 8, 2022 /PRNewswire/ — Eko, a digital health company applying machine learning in the fight against heart and lung disease, today announced that it was named to the 2022 CB Insights Digital Health 150 list. This is […]
New machine learning algorithm to support clinical decision-making in the early detection of cardiovascular disease OAKLAND, Calif., Sept. 20, 2022 /PRNewswire/ — Eko, a digital health company applying machine learning in the fight against heart and lung disease, today announced that it was awarded a $2.7 million Small Business Innovation Research (SBIR) Direct Phase II […]
The Caregility Cloud™ and Eko Connect integration addresses virtual care gaps by providing a more comprehensive physical exam experience to care teams and patients EATONTOWN, N.J. and OAKLAND, Calif., Aug. 18, 2022 /PRNewswire/ — Caregility, an enterprise telehealth platform company, and Eko, the market leader in stethoscopes for telehealth, today announced an integration partnership. Caregility’s cloud platform […]
First and only machine learning algorithm to assist healthcare professionals in identifying structural heart murmurs using a smart stethoscope OAKLAND, Calif., July 12, 2022 /PRNewswire/ — Eko, a digital health company advancing heart and lung disease detection, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Eko Murmur Analysis […]
Point-of-care cardiac screening solution honored at sixth annual awards program for improving detection of heart disease OAKLAND, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Eko, a digital health company advancing heart and lung disease detection, today announced that, for the second consecutive year, it has won the “Best Use of Artificial […]
